OUSM - ETF AI Analysis

Top Page

OShares U.S. Small-Cap Quality Dividend ETF (OUSM)

Rating:72Outperform

Price Target:―

OUSM, the OShares U.S. Small-Cap Quality Dividend ETF, earns a solid overall rating driven mainly by high-quality holdings like Royalty Pharma, Lincoln Electric, Donaldson, and MGIC Investment, which show strong financial performance, positive earnings calls, and generally supportive technical trends. These strengths are partly offset by weaker spots such as Western Union and Radian Group, where higher leverage, mixed financial results, and cash flow issues introduce some risk. The main risk factor for the fund is its focus on smaller U.S. companies, which can be more sensitive to economic and sector-specific challenges than larger, more diversified firms.

Positive Factors

Strong Dividend Focus

The ETF emphasizes quality small-cap companies that pay dividends, which can provide steady income for investors.

Sector Diversification

The fund spreads its investments across multiple sectors, reducing the risk of being overly reliant on one industry.

Healthy Asset Base

With nearly $941 million in assets under management, the ETF has a solid investor base and liquidity.

Negative Factors

High Geographic Concentration

The ETF is almost entirely focused on U.S. companies, limiting exposure to international markets and diversification.

Mixed Top Holdings Performance

Several top holdings have underperformed year-to-date, which could weigh on overall returns.

Above-Average Expense Ratio

The fund’s expense ratio is higher than many low-cost ETFs, which could reduce net returns for investors over time.

OUSM vs. SPDR S&P 500 ETF (SPY)

AUM916.71M

RegionNorth America

Expense Ratio0.48%

Beta0.70

IssuerALPS

Inception DateDec 30, 2016

Dividend Yield2.03%

Asset ClassEquity

Index TrackedO'Shares US Small-Cap Quality Dividend Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume54,287

30 Day Avg. Volume80,922

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

50.82

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering110

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

OUSM Summary

The OShares U.S. Small-Cap Quality Dividend ETF (OUSM) is an investment fund that focuses on small-cap companies in the U.S. These are smaller businesses that have strong financial health and pay consistent dividends, making them appealing for both growth and income. The ETF includes companies like Texas Roadhouse and National Healthcare, and it covers a variety of industries such as industrials, financials, and technology. Investors might consider OUSM for diversification and the potential to earn steady income from dividends. However, since it focuses on small-cap stocks, it can be more volatile than funds that invest in larger, more established companies.

How much will it cost me?The OShares U.S. Small-Cap Quality Dividend ETF (OUSM) has an expense ratio of 0.48%, which means you’ll pay $4.80 per year for every $1,000 invested. This is slightly higher than average because it is actively managed to focus on high-quality small-cap stocks that provide consistent dividend income.

What would affect this ETF?OUSM could benefit from economic growth in the U.S., as small-cap companies often thrive during periods of expansion, and its focus on high-quality dividend-paying stocks may provide stability during market volatility. However, rising interest rates or economic slowdowns could negatively impact small-cap stocks, particularly in sectors like consumer cyclical and financials, which make up a significant portion of the ETF's holdings.

OUSM Top 10 Holdings

The OUSM ETF leans heavily into U.S. small-cap stocks with a focus on quality and dividends, showcasing a strong presence in industrials and financials. National Healthcare and Donaldson Company are steady performers, bolstered by solid financial health and dividend reliability, while Royalty Pharma stands out with rising momentum in the biotech space. However, Western Union and Texas Roadhouse are lagging slightly, facing revenue challenges and inflationary pressures, respectively. With a diverse sector mix but a clear tilt toward industrials and financials, this fund balances growth potential with income stability.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NHC	National Healthcare	2.41%	$22.26M	$2.03B	34.52%	74 Outperform
DCI	Donaldson Company	2.33%	$21.56M	$10.50B	36.76%	79 Outperform
WU	Western Union	2.33%	$21.50M	$3.00B	-7.09%	69 Neutral
RPRX	Royalty Pharma	2.29%	$21.17M	$22.89B	56.10%	79 Outperform
TXRH	Texas Roadhouse	2.20%	$20.31M	$11.53B	-1.83%	72 Outperform
LECO	Lincoln Electric Holdings	2.15%	$19.81M	$13.59B	35.70%	77 Outperform
RDN	Radian Group	2.10%	$19.35M	$4.92B	13.30%	66 Neutral
SEIC	SEI Investments Company	2.08%	$19.17M	$10.65B	8.41%	79 Outperform
MTG	MGIC Investment	2.07%	$19.15M	$6.61B	23.63%	78 Outperform
SNX	TD SYNNEX Corporation	2.07%	$19.09M	$12.47B	23.51%	73 Outperform

OUSM Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

43.70

Positive

100DMA

44.01

Positive

200DMA

42.94

Positive

Market Momentum

MACD

0.21

Positive

RSI

62.46

Neutral

STOCH

66.10

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For OUSM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 44.29, equal to the 50-day MA of 43.70, and equal to the 200-day MA of 42.94, indicating a bullish trend. The MACD of 0.21 indicates Positive momentum. The RSI at 62.46 is Neutral, neither overbought nor oversold. The STOCH value of 66.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for OUSM.

OUSM Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
OUSM	―	―	$916.71M	0.48%	―
FYX	―	―	$933.66M	0.60%	―
DWAS	―	―	$746.96M	0.60%	―
GSSC	―	―	$732.24M	0.20%	―
JHSC	―	―	$647.94M	0.42%	―
EES	―	―	$627.61M	0.38%	―

Performance Comparison

OUSM

OShares U.S. Small-Cap Quality Dividend ETF

44.91

3.05

7.29%

FYX

First Trust Small Cap Core AlphaDEX Fund

―

DWAS

Invesco DWA SmallCap Momentum ETF

―

GSSC

Goldman Sachs Activebeta U.S. Small Cap Equity ETF

―

JHSC

John Hancock Multifactor Small Cap ETF

―

EES

WisdomTree U.S. SmallCap Fund

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents